Melatonin Protects Against Cocaine-Induced Blood-Brain Barrier Dysfunction and Cognitive Impairment by Regulating miR-320a-Dependent GLUT1 Expression
- PMID: 39539049
- DOI: 10.1111/jpi.70002
Melatonin Protects Against Cocaine-Induced Blood-Brain Barrier Dysfunction and Cognitive Impairment by Regulating miR-320a-Dependent GLUT1 Expression
Abstract
Cocaine abuse has been strongly linked to blood-brain barrier (BBB) dysfunction, though the exact mechanism by which cocaine disrupts the BBB remains unclear. In this study, we found that cocaine treatment reduces the expression of glucose transporter 1 (GLUT1) in brain microvascular endothelial cells, a key factor in cocaine-induced brain glucose uptake, BBB leakage, and cognitive impairment. Mechanistically, our results show that cocaine upregulates miR-320a, which in turn suppresses GLUT1 expression via the beta 2-adrenergic receptor (ADRB2). Notably, the administration of adeno-associated viruses encoding full-length GLUT1 or miR-320a inhibitors to the brain microvascular endothelium significantly mitigated cocaine-induced BBB leakage and cognitive deficits. Additionally, we discovered that melatonin, a well-known neuroprotective hormone, alleviates cocaine-induced BBB disruption and cognitive impairment. This protective effect of melatonin was mediated through the upregulation of miR-320a-dependent GLUT1 expression in brain endothelial cells via MT1 receptor-mediated inhibition of the cAMP/PKA/CREB signaling pathway. In conclusion, our findings demonstrate that cocaine downregulates brain microvascular GLUT1, leading to BBB dysfunction, and highlight melatonin as a potential therapeutic agent for treating cocaine-related complications.
Keywords: GLUT1; blood−brain barrier; cocaine; glucose; melatonin; microRNA‐320a.
© 2024 John Wiley & Sons Ltd.
References
-
- L. R. Drake and P. J. H. Scott, “Dark Classics in Chemical Neuroscience: Cocaine,” ACS Chemical Neuroscience 9, no. 10 (2018): 2358–2372.
-
- M. J. Li and S. J. Shoptaw, “Clinical Management of Psychostimulant Withdrawal: Review of the Evidence,” Addiction 118, no. 4 (2023): 750–762.
-
- R. Roque Bravo, A. C. Faria, A. M. Brito‐da‐Costa, et al., “Cocaine: An Updated Overview on Chemistry, Detection, Biokinetics, and Pharmacotoxicological Aspects Including Abuse Pattern,” Toxins 14, no. 4 (2022): 278.
-
- I. Riezzo, C. Fiore, D. De Carlo, et al., “Side Effects of Cocaine Abuse: Multiorgan Toxicity and Pathological Consequences,” Current Medicinal Chemistry 19, no. 33 (2012): 5624–5646.
-
- C. M. Shanti and C. E. Lucas, “Cocaine and the Critical Care Challenge,” Critical Care Medicine 31, no. 6 (2003): 1851–1859.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous